Carregant...
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomized placebo-controlled trial
BACKGROUND: Treatment-resistant major depressive disorder is common and potentially life-threatening in older persons, in whom little is known about the benefits and risks of augmentation pharmacotherapy. METHODS: We conducted a multi-site, placebo-controlled, randomized clinical trial to test the e...
Guardat en:
| Publicat a: | Lancet |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4690746/ https://ncbi.nlm.nih.gov/pubmed/26423182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)00308-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|